Terms: = Leukemia AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9 AND Prognosis
91 results:
1. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia.
Nakamura A; Masuya M; Shinmei M; Tawara I; Nosaka T; Ono R
Blood Adv; 2024 May; 8(9):2193-2206. PubMed ID: 38452334
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid leukemia Harboring
Jiang B; Zhao Y; Luo Y; Yu J; Chen Y; Ye B; Fu H; Lai X; Liu L; Ye Y; Zheng W; Sun J; He J; Zhao Y; Wei G; Cai Z; Huang H; Shi J
Cell Transplant; 2024; 33():9636897231225821. PubMed ID: 38270130
[No Abstract] [Full Text] [Related]
3. Iron overload promotes the progression of MLL-af9 induced acute myeloid leukemia by upregulation of FOS.
Yang F; Cui X; Wang H; Zhang D; Luo S; Li Y; Dai Y; Yang D; Zhang X; Wang L; Zheng G; Zhang X
Cancer Lett; 2024 Feb; 583():216652. PubMed ID: 38242196
[TBL] [Abstract] [Full Text] [Related]
4. Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia.
Xie X; Zhang W; Zhou X; Xu B; Wang H; Qiu Y; Hu Y; Guo B; Ye Z; Hu L; Zhang H; Li Y; Bai X
Oncogene; 2023 Dec; 42(50):3657-3669. PubMed ID: 37872214
[TBL] [Abstract] [Full Text] [Related]
5. Interleukin-6 Facilitates Acute Myeloid leukemia Chemoresistance via Mitofusin 1-Mediated Mitochondrial Fusion.
Hou D; Zheng X; Cai D; You R; Liu J; Wang X; Liao X; Tan M; Lin L; Wang J; Zhang S; Huang H
Mol Cancer Res; 2023 Dec; 21(12):1366-1378. PubMed ID: 37698549
[TBL] [Abstract] [Full Text] [Related]
6. Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::af9-induced leukaemic cells.
Patnana PK; Liu L; Frank D; Nimmagadda SC; Behrens M; Ahmed H; Xie X; Liebmann M; Wei L; Gerdemann A; Thivakaran A; Humpf HU; Klotz L; Dugas M; Varghese J; Trajkovic-Arsic M; Siveke JT; Hanenberg H; Opalka B; Dührsen U; Reinhardt HC; Guenther U; von Bubnoff N; Khandanpour C
Br J Haematol; 2023 Sep; 202(5):1033-1048. PubMed ID: 37423893
[TBL] [Abstract] [Full Text] [Related]
7. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
8. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.
Casado P; Rio-Machin A; Miettinen JJ; Bewicke-Copley F; Rouault-Pierre K; Krizsan S; Parsons A; Rajeeve V; Miraki-Moud F; Taussig DC; Bödör C; Gribben J; Heckman C; Fitzgibbon J; Cutillas PR
Signal Transduct Target Ther; 2023 Feb; 8(1):80. PubMed ID: 36843114
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive molecular understanding of pediatric acute myeloid leukemia.
Shiba N
Int J Hematol; 2023 Feb; 117(2):173-181. PubMed ID: 36653696
[TBL] [Abstract] [Full Text] [Related]
10. The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.
Liu XX; Pan XA; Gao MG; Kong J; Jiang H; Chang YJ; Zhang XH; Wang Y; Liu KY; Chen Z; Zhao XS; Huang XJ
Int J Lab Hematol; 2023 Apr; 45(2):195-203. PubMed ID: 36358022
[TBL] [Abstract] [Full Text] [Related]
11. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.
Isobe T; Takagi M; Sato-Otsubo A; Nishimura A; Nagae G; Yamagishi C; Tamura M; Tanaka Y; Asada S; Takeda R; Tsuchiya A; Wang X; Yoshida K; Nannya Y; Ueno H; Akazawa R; Kato I; Mikami T; Watanabe K; Sekiguchi M; Seki M; Kimura S; Hiwatari M; Kato M; Fukuda S; Tatsuno K; Tsutsumi S; Kanai A; Inaba T; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Kotecha RS; Cruickshank MN; Ishikawa F; Morio T; Eguchi M; Deguchi T; Kiyokawa N; Arakawa Y; Koh K; Aoki Y; Ishihara T; Tomizawa D; Miyamura T; Ishii E; Mizutani S; Wilson NK; Göttgens B; Miyano S; Kitamura T; Goyama S; Yokoyama A; Aburatani H; Ogawa S; Takita J
Nat Commun; 2022 Aug; 13(1):4501. PubMed ID: 36042201
[TBL] [Abstract] [Full Text] [Related]
12. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
[TBL] [Abstract] [Full Text] [Related]
13. A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid leukemia Cells.
Zhang K; Gao L; Wang J; Chu X; Zhang Z; Zhang Y; Fang F; Tao Y; Li X; Tian Y; Li Z; Sang X; Ma L; Lu L; Chen Y; Yu J; Zhuo R; Wu S; Pan J; Hu S
Pathol Oncol Res; 2022; 28():1610447. PubMed ID: 35832114
[TBL] [Abstract] [Full Text] [Related]
14. GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia.
Liu L; Patnana PK; Xie X; Frank D; Nimmagadda SC; Su M; Zhang D; Koenig T; Rosenbauer F; Liebmann M; Klotz L; Xu W; Vorwerk J; Neumann F; Hüve J; Unger A; Okun JG; Opalka B; Khandanpour C
Leukemia; 2022 Sep; 36(9):2196-2207. PubMed ID: 35804097
[TBL] [Abstract] [Full Text] [Related]
15. Polycomb complexes in MLL-af9-related leukemias.
Sparavier A; Di Croce L
Curr Opin Genet Dev; 2022 Aug; 75():101920. PubMed ID: 35609423
[TBL] [Abstract] [Full Text] [Related]
16. Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia.
Zhou J; Chen X; Zhou P; Sun X; Chen Y; Li M; Chu Y; Zhou J; Hu X; Luo Y; Yuan W; Wang G
Biochem Biophys Res Commun; 2022 Apr; 600():29-34. PubMed ID: 35182972
[TBL] [Abstract] [Full Text] [Related]
17. A novel upregulated LncRNA-AC026150.8 promotes chemo-resistance and predicts poor prognosis in acute myeloid leukemia.
Zhang H; Zhao Y; Liu X; Liu Y; Wang X; Fu Y; Fu S; Zhang J
Cancer Med; 2021 Dec; 10(23):8614-8629. PubMed ID: 34664783
[TBL] [Abstract] [Full Text] [Related]
18. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
Khateb A; Deshpande A; Feng Y; Finlay D; Lee JS; Lazar I; Fabre B; Li Y; Fujita Y; Zhang T; Yin J; Pass I; Livneh I; Jeremias I; Burian C; Mason JR; Almog R; Horesh N; Ofran Y; Brown K; Vuori K; Jackson M; Ruppin E; Deshpande AJ; Ronai ZA
Nat Commun; 2021 Sep; 12(1):5397. PubMed ID: 34518534
[TBL] [Abstract] [Full Text] [Related]
19. Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications.
Lopes M; Duarte TL; Teles MJ; Mosteo L; Chacim S; Aguiar E; Pereira-Reis J; Oliveira M; Silva AMN; Gonçalves N; Martins G; Kong IY; Zethoven M; Vervoort S; Martins S; Quintela M; Hawkins ED; Trigo F; Guimarães JT; Mariz JM; Porto G; Duarte D
Blood Adv; 2021 Aug; 5(16):3102-3112. PubMed ID: 34402883
[TBL] [Abstract] [Full Text] [Related]
20. Mature B cell acute lymphoblastic leukaemia with KMT2A-mllt3 transcripts in children: three case reports and literature reviews.
Cui Y; Zhou M; Zou P; Liao X; Xiao J
Orphanet J Rare Dis; 2021 Jul; 16(1):331. PubMed ID: 34330316
[TBL] [Abstract] [Full Text] [Related]
[Next]
